Hepatitis Vaccine Market Analysis of Global Market Trends With Size, Share, Growth, Demand And Industry Analysis, Top Leading Players by- Merck and Company, GlaxoSmithKline, Sanofi Pasture, CSL Behring GmbH, Novartis AG and Pfizer Inc. to Forecast by 2026

Hepatitis Vaccine Market – Insights

Hepatitis is an infectious disease caused by the hepatitis virus. Based on the type of virus, there are three types of hepatitis include hepatitis A, hepatitis B, and hepatitis C. Hepatitis virus also leads to diseases such as liver cirrhosis, hepatocellular carcinoma, and liver failure. A major source of the infection is contact with body fluids of the infected person. Hepatitis A and hepatitis B can be prevented through vaccination. Hepatitis is more common in children and the prevalence of hepatitis B is more compared to hepatitis A worldwide. Engerix-B, Havrix (Glaxosmithkline), Recombivax, Vaqta (Merck and Company), Euvax – Avaxim (Sanofi Pasteur), and Shanvac B (Shantha Biotech) are some of the leading brands of hepatitis vaccine.

For more information, Request PDF Brochure @ https://www.coherentmarketinsights.com/insight/request-pdf/1537

Hepatitis Vaccine Market: Drivers

Increasing awareness regarding the advantages of hepatitis vaccination is expected to propel growth of the market. Moreover, increasing prevalence of hepatitis is a major factor boosting growth of the global hepatitis vaccine market.  For instance, according to World Hepatitis Report published in 2017 by the World Health Organization (WHO), around 325 million people worldwide are living with chronic hepatitis B virus infection (HBV) or hepatitis C virus (HCV) infection. Moreover, around 1.34 million deaths were caused due to viral hepatitis and around 1.75 million people were infected with hepatitis B virus infection in 2015.

Furthermore, increasing population is expected to contribute to growth of the hepatitis vaccine market. For instance, according to the World Population Report published in 2017, world population would surpass mark of 9 billion by 2025 thereby adding more live birth annually. According to guideline published by WHO, vaccine for hepatitis B has to administer within first 24 hour of the birth in order to prevent the hepatitis B infection in infants.

LIMITED TIME OFFER – Hurry Up!

Get Discount For Buyers UPTO 25% OFF On Any Research Report
Apply Promo Code “CHRISTMAS2020” And Get Instant Discount Of USD 1000
Buy Now This Premium Report to Grow your Business @ https://www.coherentmarketinsights.com/insight/buy-now/1537

Hepatitis Vaccine Market: Restraints

A major factor hindering growth of the market is high cost of hepatitis vaccines. Several government and international organizations such as the WHO are focused on offering the hepatitis vaccine at affordable rates. Moreover, accessibility of these vaccines is still low in emerging regions of Asia Pacific and Africa, both with significant prevalence of hepatitis. These factors are expected to hinder growth of the market.

Hepatitis Vaccine Market: Opportunities

There is no vaccine for hepatitis C. Therefore, key players in the market can focus on developing vaccine for hepatitis C, which is the most common type of hepatitis after hepatitis B. Moreover, existing vaccines for hepatitis B are ineffective in adults and diabetic patients. Such scenarios offer lucrative growth opportunities for the market players.

Hepatitis Vaccine Market: Regional Analysis

North America is expected to account for the largest market share over the forecast period. This is attributed to increasing prevalence of hepatitis in the region. For instance, according to the Centers for Disease Control (CDC), in 2016, a total of 2,967 new cases of acute hepatitis C were reported and a total of 41,200 persons were newly infected with hepatitis C in 2016 in the U.S.

The market in Asia Pacific is driven by high prevalence of hepatitis in the region. For instance, according to World Hepatitis Report, 2017, 154 million people in Asia Pacific were suffering from hepatitis B. Moreover, according to the WHO, 2% to 5% of general population is affected with chronic hepatitis in Asia Pacific. The market in Middle East & Africa is also driven by high prevalence of hepatitis B in the region.

To get a detailed table of content (ToC), please click – https://www.coherentmarketinsights.com/ongoing-insight/toc/1537

Hepatitis Vaccine Market: Competitive Landscape

Key players in the market are focused on product approval and launch to expand their product portfolio. For instance, in September 2017, Dynavax Technologies Corporation received the U.S. Food and Drug Administration (FDA) approval for its hepatitis B vaccine HEPLISAV-B to be used in adults.

Major players operating in the global hepatitis vaccines market include, Novartis AG, Pfizer Inc., Merck and Company, GlaxoSmithKline, Sanofi Pasture, and CSL Behring GmbH.

Hepatitis Vaccine Market: Taxonomy 

By Indication

• Hepatitis A
• Hepatitis B

By Vaccine Type

• Recombinant Vaccine
• Inactivated Vaccine

By Distribution Channel

• Hospitals
• Retail Pharmacy
• Online Pharmacy

By Region

• North America
• Latin America
• Europe
• Asia Pacific
• Middle East and Africa

Amongst indication, hepatitis B vaccine holds larger market share due to higher prevalence of hepatitis B infection and presence of different companies in the production and marketing of these vaccine. Recombinant vaccine is largest shareholder in vaccine type segment as it is most commonly used in the hepatitis B vaccine. Amongst distribution channel retail pharmacy holds major share.

Other Related Reports:

HEPATITIS DRUGS MARKET ANALYSIS

ANTI-INFECTIVE DRUGS MARKET ANALYSIS

PLANT-BASED BIOLOGICS MARKET ANALYSIS

Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies, to not-for-profit organization, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.

To know more about us, please visit our website – www.coherentmarketinsights.com

Contact:

Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837

This content has been distributed via CDN Newswire press release distribution service. For press release enquires please mail us at contact@cdnnewswire.com.